1.
Pharmacokinetics and bioequivalence of valaciclovir hydrochloride tablets
盐酸伐昔洛韦片的人体药动学及生物等效性
2.
Evaluation of Uncertainty Measurement in the Content Determination of Valaclovir Hydrochloride Tablets by UV
盐酸伐昔洛韦片含量测定的不确定度评定
3.
Preparation and quality standard of valaciclovir hydrochloride gel
盐酸伐昔洛韦凝胶剂的制备与质量控制
4.
Bioequivalence of Valaciclovir Capsules in Human
盐酸伐昔洛韦胶囊的人体生物等效性研究
5.
Inhibitory Effects and Clinical Effects of Different Dose Valaciclovir Hydrochloride in the Treatment of Genital Herpes Patients;
不同剂量盐酸伐昔洛韦治疗生殖器疱疹的临床观察及实验研究
6.
Study and Determination on Voltammetric Behavior of Valaciclovir Hydrochloride and Indometacin and Several Drugs
盐酸伐昔洛韦、吲哚美辛等药物伏安行为的研究与测定
7.
Preparation and Mucoadhesive Property of Valaciclovir Bioadhesive Microspheres
伐昔洛韦生物黏附微球的制备与黏附性能研究
8.
Determination of ganciclovir by acid chrome blue K fading spectrophotometry
酸性铬蓝K退色光度法测定更昔洛韦的含量
9.
Clinical effect and nursing observation of recombinant human interferonα-2b combined with acyclovir on treating herpes zoster
干扰素联合伐昔洛韦治疗带状疱疹的临床效果及护理实践
10.
Curative Effect of Combination of Valaciclovir and Mycobacterium for Recurrent Genital Herpes
伐昔洛韦联合乌体林斯治疗复发性生殖器疱疹(RGH)的疗效分析
11.
Simultaneous and Rapid Determination of Aciclovir, Ganciclovir and Penciclovir in Plasma Using Solid-phase Extraction and High-performance Liquid Chromatography;
SPE-HPLC法同时快速测定血浆中更昔洛韦、阿昔洛韦和喷昔洛韦的浓度
12.
Comparison of Effects of Ganciclovir and Acyclovir on Adult Varicella
更昔洛韦和阿昔洛韦治疗成人水痘的疗效比较
13.
Method for determining ganciclovir quantity contained in ganciclovir cream
更昔洛韦乳膏中更昔洛韦含量测定方法的研究
14.
Therapeutic effects of ganciclovir and aciclovir on varicella
更昔洛韦与阿昔洛韦治疗水痘临床疗效分析
15.
Determination of Antivirus Activity of Valaciclovir Hydrochloride to Herpes Simplex Virus in Vitro.
盐酸万乃洛韦体外抗单纯疱疹病毒活性的测定
16.
Study on Valaciclovir Hydrochloride Micro-porous Osmotic Pump Tablets;
盐酸万乃洛韦微孔渗透泵控释片的研究
17.
A HPLC method was established for the determination of Aciclovir in Aciclovir urea cream.
建立阿昔洛韦尿素乳膏中阿昔洛韦含量的HPLC测定方法。
18.
In 153 cases of prevention research,88 were in GCV group and 65 in ACV group;
预防研究共153例，更昔洛韦组88例，阿昔洛韦组65例。